BiotechTube
Home/Pipeline/Proprietary RNA Therapeutics Pipeline

Proprietary RNA Therapeutics Pipeline

Not Specified

Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Pre-clinical
Status
Active
Company
ACON Pharmaceuticals

About ACON Pharmaceuticals

ACON Pharmaceuticals is a private, US-based company specializing in advanced drug delivery systems and RNA therapeutics. It operates a hybrid business model combining proprietary technology platform development, internal pipeline programs, and a broad range of contract services for the biopharma industry. With deep expertise in lipid nanoparticles (LNP), liposomes, and other delivery technologies, ACON positions itself as an integrated partner for developing next-generation complex pharmaceuticals and 505(b)(2) products.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved